Good morning. Welcome to the second quarter analyst presentation for BH PCL. As is the usual case for this presentation format, we will begin with an overview by Neil Sorrentino, our Chief Global Strategist. In this quarter, following that, will be the financial presentation by Khun Jittima, our Deputy CFO, and following on that, a number of business updates which will be presented by myself and Wisut Ua-Anant, our Chief Digital MarTech Officer. Without further ado, I'd like to hand this over to Neil, please. Good day together. My name is Neil Sorrentino, Chief Global Strategist for the company. We welcome you to the Q2 2021 takeaways for Bumrungrad Public Company Limited. For the quarter, we're going to take a little bit different tact for the Q2 presentation. I've asked our staff to give a much deeper dive into the composition of the data that is driving our revenue. As you have seen already, the quarter was a significantly stronger quarter than Q1 2021, and of course, much stronger than Q2 2020, because that was the peak of the beginning of the COVID impact all over Thailand. The theme for us over the last really 15 months has been agility, rotation of the business, and the compositional change of that business as we moved away from international because borders were closed for the most part and focused on Thai business, expat business, and some international business that we did experience in Q2 on an emergency medical treatment basis, which generates revenue in a particular category called alternative hospital quarantine, and we'll talk more about that in a moment. You're going to be able to see this quarter how it is that we're generating this kind of revenue just essentially looking at business in Thailand. Let's talk about the top-line key takeaways of the quarter. For the quarter, the quarter-over-quarter revenue was 12.8%. There was very, very strong support both from COVID revenues amongst Thai people, expats. You will see when I go through this, the additional level of detail which mattered to about a 25% increase of alternative hospital quarantine patients, and these were ill patients that came in internationally. As you know now in Q3 forward, the borders are completely shut. There's no one bringing in any international patients, and that includes us. The presenters today, especially Daniel and Khun Wisut, our Chief Digital MarTech Officer, are going to go through the level of details that drove this 12.8% revenue increase. Just on the Thai business alone, the amount of additional incremental revenue quarter-over-quarter was THB 171 million. That came from a variety of different programs, not only COVID treatments and COVID screenings, but it also came from online and offline digital platforms. In addition, we launched our own version digitally of a Moderna vaccine program rollout, for which, in the end, we purchased an advance purchase and advance payment a little over 17,000 jab vaccinations, which we'll be receiving in the middle of Q4 sometime as we are told by the Government Pharmaceutical Office, which is a sub-entity of the government. That entire allotment is sold out in advance, and we'll administer that in Q4 and rolling into Q1 2022. Let's get into some level of the detail on the business for Q2. For the overall market, I've mentioned 12.8% quarter-over-quarter. While not meaningful in terms of a comparative nonetheless from Q2 2020, the growth was quite significant, but not of use in terms of comparing because they're really not comparable. Next slide. If you look deeper into the Thai revenue, you can see the chart below. You can see for the Thai revenue, it increased quarter-over-quarter 12.1%. When you look at the numbers inside that percentages from COVID business, meaning screenings, meaning treatments, the amount of revenue generated was an incremental THB 95 million. The amount of online revenues increased by THB 23 million. Increase on our telemedicine services was THB 20 million, and then others was about THB 34 million. Daniel later is going to talk about that level of detail. Next slide. Similar story for expats. The growth for Q2 is up 7.2%. Again, on the quarter, a pretty significant growth. Of course, a significant growth over 2020. When you look deeper into what the 7.2% entail, there was about THB 34 million, again, related to COVID screenings and treatments. Online revenues, almost THB 9 million. All others made up the difference. When you look at the nationality, when you think about expat for us, there's two types of nationalities. You have all those except Middle Eastern nationalities. You have all other. For us, all other in the quarter, we saw significant growth. Bangladesh was up 11%. These are by nationality. Germany up 9.7%. Japan up 9.5%. The U.S. up 9.3%. When you look at the net revenue growth, Japan was number one at almost 30% growth quarter-over-quarter. I'm talking about 2020 versus 2021. Australia, almost 17%, India, 13%, et cetera. We had strong, broad year-over-year growth, of course, but very strong quarter-over-quarter growth. You can see the monthly performance, the green line versus the dark line. Next slide. This is all international. This is everything that we define all international, which includes all of it. The growth was almost 19% quarter-over-quarter. Recall now that this includes AHQ revenue that was fairly substantial in the quarter because it was still allowing emergency international patients in. This is, as an example, Indochinese patients and others. Can we show that detail? Next slide. When you look at what drove some of those numbers on the growth percentage, you can see by nationality and country, Kuwait, Qatar, Myanmar, Mongolia. The first three, while these are percentages, when you look at the revenue behind them, they were fairly substantial. We still maintain a fairly good volume of business from Middle Eastern patients, those that have been here and a few that do trickle in. The rest, you can see the distribution. Bangladesh was pretty strong in the quarter. Bahrain, Oman. On the larger volume-related revenue, the top three were the most significant contributors on revenue, especially Q- over- Q. In some cases, year-over-year for the quarter. Total international was up almost 19% for the quarter. Again, when you look at the distribution of contribution of the revenue drivers, this was an important one for us too, beyond Thai, beyond expat. Next slide. Middle East. Again, another major contributor to our revenue base quarter-over-quarter, almost up 25%. Against Q2 2020, it's going to be less because the borders at some portion of Q2 2020 to Q2 2020, there was more of a free flow starting to close down. Against Q1, it was substantially higher because we were able to bring in patients who were quite ill and approved by the Ministry of Public Health. Next slide. Indochina, very much a similar story. Strong uptick in revenue over quarter. 28.3% from Q1. The year-over-year change was very high because by that time, Myanmar was just about shut, although there are other parts of Indochina, Cambodia, Laos, et cetera. I'll show you that. Next slide. On a consolidated basis, when you look at AHQ and ASQ performance for the quarter, you will see that for the AHQ, THB 536 million for Q2, THB 428 million for Q1 2021, and that represented about 25%. More importantly, when you look over to the right, you'll see a conversion of 67%. As I've explained in the past, there is revenue generated that is associated with being in the AHQ, which means quarantined for 10 to 14 days, depending. There's some revenue generated there, but the 67% has to do with, in addition, revenue that is generated by those patients who then use our inpatient and outpatient facilities. In a similar way, although more transitionary, you have the ASQ, where the conversion rate for the quarter was 16. In Q1, it was only 10%. That rose as well for the quarter for us. All of the indices on revenue drivers, on market drivers, on digital platform drivers were all striking a very positive ability to drive revenue in the quarter, and as a result, drove us up to almost 13% quarter-over-quarter performance. Okay. Please go back to the highlights. As we look at expectations going forward, the latest information that we hear and see through governmental agencies, through government-sponsored organizations, through commercial banking expectations, specifically Bank of Thailand and Tourism Authority of Thailand. They are guiding that given the huge surge in COVID-19 patients, meaning infections, case rates, infection rates, death rates, given the current rising orientation, and just today we saw that there was a record high over 22,000 infections yesterday in Thailand. A reasonably good portion of them in the greater Bangkok area and provinces surrounding Bangkok. There is a high level of uncertainty, low consumer confidence, high savings as a result of people not wanting to spend money, wanting to husband money because unsure where this is all going. For us, when we look at what used to be the biggest portion of our business, which was international, we're really not expecting that to return to any level of normal performance until sometime in 2022. When that is in 2022 will really depend upon the government vaccination program and the availability of additional vaccines being brought into the country, which as you know, media has reported that it's been slow in coming into the country and also slow in its distribution. Many of the experts expect that to change and get better as we move into Q4, and beyond. That's a major limiter to how it is that the country will open up. Firstly, the sandboxes, both in Phuket, although it has opened up, it's been slow. Samui is just about to open up, but slow. Need to bend that curve downward in the number of infections in order to create stronger consumer confidence. In the meantime, we as a company recognized this because we're looking around the world and looking at surges and watching how it is that these surges continued growing upward with higher and higher infection rates, and then declining as the curve was bent downward. We anticipated that we'd have to focus on the business at hand, which is what we have in Thailand. Now even in the third quarter, with the borders now shut, we even have to be more reliant on the business here in Thailand, and we're prepared to do that. I think Q2 showed you as investors and interested people in our company that we've been quite successful at doing that. At our board meeting this past week, our board of directors looked at the different possibilities and variations on the interim dividend payment, and it being a strong value company with strong cash reserves. The board on Wednesday evening approved a dividend payout on EPS of about 300% of EPS, and the amount is a little over THB 900 million, and that'll be paid in the early part of September to shareholders of record. A strong commitment once again to our shareholders owning shares in our company. As of the end of July, the company was in very strong position, having THB 8.3 billion in cash. Of course, those who follow us know we're in a negative debt situation. For Q3 guidance, with almost 13% growth in top-line revenue. It's uncertain about where we will be in Q3 and Q4. Strictly predictable and driven by the number of infections, the rate of the lockdown, the extent of the lockdown, the duration of the lockdown. We will continue to execute to our offline and digital platform to drive supplemental revenue for those people that are concerned about coming into the campus. Of course, there'll be revenue driven by, unfortunately, at least at this point in time, will be driven by COVID screenings, COVID treatment, and vaccinations, which we're very much focused on. Which you'll hear a great deal more about how we're driving our orientation as we look at our business composition having been different really over the last two to three quarters. Thank you. Good morning, everyone. I'm Khun Jittima, Deputy CFO. I am pleased to report the financial performance of the second quarter 2021 and the first half of 2021. First, financial highlight. Despite the surge in COVID-19 cases in Thailand in mid-December 2020 and continuing into 2021, the Thai and expat visits continue to grow year on year. Restrictions on travel and medical tourism continue to impact the company international business, especially when compared to the first high base of the first half of the first quarter of the previous year, when COVID-19 was only marginally impacting the company's performance. The second quarter of 2021, revenue increased by 23.2% year on year. This was mostly due to an increase in revenue from Thai patients by 27.3% and non-Thai patients by 18.5%. EBITDA increased by 81.7%, with EBITDA margin of 19.1%, increased from 12.9% in the second quarter of the previous year. Net profit and diluted EPS increased significantly by 387.2%, with the net profit margin of 7.2%, compared to 1.8% in Q2 2020. The Q2 2021 performance improved from the Q1 2021, primarily due to the increase in revenue from Thai, expat, and international patients from alternative hospital quarantine service. Revenue increased by 12.7% from Q1, and net profit grew by 137.5%. For the first half 2021, revenue decreased by 13.5% from the previous year. EBITDA down by 36.6%, with EBITDA margin of 17.3%, compared to 23.6% in the first half of 2020. Net profit decreased by 62%, with net profit margin at 5.4% in the first half of 2021, compared to 12.3% in the first half of 2020. The decrease mostly attributed to the limited impact of COVID-19 during Q1 2020. Move on to financial performance. The company reported total revenue in the second quarter of 2021 of THB 3,020 million. This amount represented a 23.2% increase from the second quarter of last year. For the first half of this year, total revenue was THB 5,694 million, a 13.5% decrease year-over-year. This was mostly due to a decrease in revenue from non-Thai patients by 32.3%, offset with an increase from Thai patients by 13.1%. Revenue contribution by nationality. As restrictions on travel and medical tourism continue to impact the company international business and our continued marketing for local market, the percentage of revenue from Thai patients increased to 54% for both second quarter and the first half of 2021, compared to 52% in the first quarter of 2021 and 41% in the first half of 2020. Revenue contribution by services. For the 2nd quarter of 2021 and 2020, the proportion of revenue from inpatient services and outpatient services was the same at 52% and 46%. For the 1st half of 2021, the proportion of revenue from inpatient services slightly decreased from 54% to 53%, mostly due to a slight decrease in average length of stay for non-Thai segment. Revenue contribution by payer type. There was a change in payer mix due to COVID-19 pandemic impact. The government third-party payer contribution was reduced from 19% last year to 11% for the 1st half of this year due to restrictions on travel and medical tourism for Middle East business. Self-pay also was increased from 60% to 64% in the 1st half of this year, mostly due to an increase in Thai and expat self-pay. Insurance contribution also increased from 19% to 22% in the first half of 2021 due to an increase in Thai and expat insurance business. EBITDA was THB 576 million in the second quarter of 2021, increased by 81.7% from THB 317 million in the second quarter of 2020. The increase was mostly due to the increase in revenue and also our cost management programs related to workforce management, contract management, and inventory management. EBITDA for the first half of 2021 was THB 986 million, a 36.6% decrease from THB 1,555 million in the first quarter of last year. The decrease was mostly attributed to the limited impact of COVID-19 during the first half of 2020. EBITDA margin was 19.1% in the second quarter of 2021, increased from 12.9% in the second quarter of last year. EBITDA margin was 17.3% for the first half of 2020, decreased from 23.6% in the first half of last year. Net profit for the second quarter of 2020 was THB 216 million, increased by 387.2% from THB 44 million in the second quarter of the previous year. Net profit for the first half of this year was THB 308 million, a 62% decrease from THB 810 million in the first half of 2020. Net profit margin was 7.2% in the second quarter of 2021, compared to 1.8% in the second quarter of 2020. For the first half of 2021, net profit margin was 5.4%, compared to 12.3% in the first half of last year. Net debt to EBITDA was 0.6 times for the first half of 2021, slightly higher than year 2020 due to less EBITDA in the first half of this year. Net debt to equity was 0.1 times as of June 2021, almost the same as December 2020. Interest coverage ratio was dropped to 15.1 times due to less EBITDA. When consider bond covenant requirement, which required to have net debt to EBITDA at less than 3.25 times and net debt to equity at less than 1.7 times, the current net debt to EBITDA and net debt to equity for the first half of 2021 still a lot lower than the bond covenant requirement. Thank you. Thank you, Khun Jittima. I'd like to start off with the business updates with the Q2 2021 snippets. This is essentially a new way for us to present some key numbers during the quarter, which we believe would be of interest to you. Let's start off with the first item. You may notice that under The 1 direct accretive revenue, this is essentially revenue generated directly incrementally from new and existing reactivated patients. What we mean by that is reactivated patients being people who have not visited the hospital over the last two years, having once again used services at Bumrungrad BH PCL. The 1 is essentially a partnership loyalty program between Central Group and ourselves, and it has proven to be very successful in driving additional spending and incremental revenue to the hospital. We calculate approximately THB 291 million in revenue generated in the second quarter of 2021, which is a growth of 27% Q on Q or 2,930% year-over-year. The reason for that large growth number is due to the start of the program in May of last year. Due to that, the low base effect, you need to take into account as well. The other channel, which was significant during the quarter, were referrals from other hospitals, generating approximately THB 211 million in revenue. Referral from other hospitals includes hospitals that are under the Bumrungrad Health Network and from other local hospitals within Thailand who have referred either complicated cases or overflows to Bumrungrad Hospital itself. This number continued to grow and has continued that trend over the last several quarters already, generating 39% quarter-over-quarter in growth and 21% year-over-year in growth. Something that many people would be interested to know is COVID-19 revenue. Revenue generated from COVID-related treatments and screenings amounted to approximately THB 198 million during the quarter, a growth of 321% quarter-over-quarter or 372% year-over-year. The growth has been significant and is in direct proportion to the number of new COVID cases that we're currently seeing during the third wave, which continues still unabated since May. On to telemedicine and home care revenues. That amounted to THB 115 million during the quarter and continued to grow quite strongly, up 31% quarter-over-quarter, 11% year-over-year. The telemedicine and home care services has grown quite well given the reluctance of people to seek healthcare on premise at the hospital. We have digitally engaged with the patient through telemedicine and home care services, and that demand continues strongly. On online store and digital products, these are essentially products we sell on our online store, both in the website and through the Bumrungrad app. These include packages such as screenings, and other ancillary products, which we are selling online and digitally. These products have shown remarkable growth, 618% Q on Q or over 103% year-over-year. The online store is a relatively new development, which only begun to take root since the beginning of last year. We've been very proud and pleased with the uptake of this channel in driving revenue growth to the hospital. On to the COVID-19 vaccination program. The hospital has received very good feedback from patients who have received vaccinations, both government provided and also privately funded vaccines such as Moderna. We've also begun to organize inoculations for the Pfizer vaccines that have been received thanks to the generosity of the U.S. government for healthcare and frontline medical care workers. Some of these have been also allocated to expats, and we have also begun to organize bookings for expats as well. I'd like to show you a clip on the vaccination. These have been designed specifically for Japanese expats. [Non-English content] In addition to providing vaccinations, we have also opened the opportunity for patients to buy checkup packages under the very popular buy one get one free campaign. This was again reinitiated during the June, July period to sell packages to people coming for vaccinations. As you can see, it generated approximately THB 19.5 million in additional revenue for the hospital, amounting to 801 packages. During the quarter, we also launched two key clinics. The Pride Clinic, essentially providing transgender or sexual reorientation services to patients seeking those services. These are rather extensive. Not only surgical, but includes multidisciplinary approaches to treating and preparing patients for these kinds of surgical procedures. Hormone therapy, and other areas which we hope to continue to expand. The market is significant, not only within Thailand, but also targeting international patients, specifically in China, where we see high demand from patients, and we expect that once the country opens up, we can tap into this high growth area. Secondly, the allergy clinic, which we have already established, but we have enhanced with services related to home care and treatments. These are just a few slides of the launch of the Pride Clinic, which was very well received by the public. To our target in how we expect to continue growing our business. You may know, the international market continues to be relatively closed in terms of the continued travel restrictions that we have in Thailand. Our focus continues to be on the Thai and expat segment. What are we doing in growing that area? We're looking at expanding our digital connections with our patients through social media, through content, in growing awareness and demand for healthcare related issues. We are observant of the fact that throughout the world, due to people's reluctance to come to hospitals, a number of underlying health issues will start to take increasing prominence in terms of their effect on people's health. Due to the lack of health screenings, due to the lack of follow-ups with physicians, et cetera, and also the lack of activity at people's homes. As a result, we continue to want to engage with our patients in highlighting underlying health issues that may continue to affect them during this time of lockup. On to the expat market. As you can see, we've targeted four key categories of expats. The Japanese expat market, the American expat market, the Chinese expat market, and the Indian expat market. All four have specific key focuses, as you can see on these slides. For Japanese, OBGYN, sports and joint. On Chinese, oncology, and also IVF, as is well known to be in high demand. For the Indian market, which is significant in Thailand, oncology and colorectal are key areas of focus. For American expats in general, OBGYN and also oncology as well have been key focuses for us. These are areas of significant strength for us, and we expect to continue to utilize these to further penetrate those markets. As you have seen, the growth in the expat market has been rather encouraging during the quarter, and has continued to be the case since the previous quarters as well. That concludes my part of the business update. The next part will be presented by Wisut, our Chief Digital MarTech Officer, who will provide us with exciting updates on what we are doing in this area. Wisut, please. Hi, everyone. I am Wisut Ua-Anant, Chief Digital MarTech Officer at Bumrungrad. Today, I would like to update you about the MarTech work for Q2. First one, about the Bumrungrad Online Store. This is the second year of the online store that we did. Currently, we have more than 349 package sale from 42 clinics in the online store. We still have more clinics in Bumrungrad. We have more than 60 clinics. We can add more in the future. The approach that we did for the online store is totally different from the competitor. We use the approach that call direct-to-consumer approach. What it mean for this? The direct-to-consumer approach, it means all the data is going to collect by us. This year, I used the data from last year to retargeting the customer for this year. Also, we have all the 360 view of the behavior of customer that we can find the package more and lookalike model to find more customer to buy as well. It is totally different from the competitor that use Shopee, Lazada to sell package. That way, it means all the data belong to that platform. They cannot do like us. That is why they have to use the platform from Lazada and Shopee. We did all of this in in-house development in Bumrungrad for the whole thing. Okay, let me continue. Currently, we already have the vaccine store. This is the example. Vaccine store, we have women's center, we have children's center. Specifically for each clinic and each target for the customer. We also have the nutrition and also teleconsultant for nutrition package in here. This one, genetic store. Genetic store is the new store that we also did the new promotion with the insurance. Insurance can redeem the point and use the point to convert to be the discount code to get the genetic for free. Currently, our online store support for exchange the point, exchange the discount code with the partner. Okay. For this one is the revenue. This one, last year, online store, we launched for the first year. We got THB 36 million in 36 days on that time when we have the buy one, get one campaign. For this year, you can see April and May. It's growth because we have buy one, get one campaign on that period. For June and July, we not have the buy one, get one. We still can maintain the revenue growth from after that. I will show you what is the reason we can make it growth. This year, we can make THB 65 million in 45 day. It's more than 100% from last year. We also make the overall for our Bumrungrad Online Store until July, it's more than THB 100 million already. This one we achieve more 100% of the total year last year. This is a new feature that we did on July. We integrate with The 1 point. From The 1 point to convert to be the redemption discount for the Bumrungrad Online Store. People also earn the payment that they pay in here to be the point of The 1 as well. We already make this one happen in online. This one is The 1 that is an incredible thing for me. I did Bumrungrad Online Store in many companies, but I never see that I can sell a THB 500,000 gift card. I can make this thing happen in Bumrungrad right now, and we sell the best selling as well for this one. That's why we can maintain the revenue growth from the gift card THB 500,000. We offer right now if people buy THB 500,000, they can get THB 25,000 increased for their purchase more. Totally, for the revenue currently is more than THB 63 million from gift card that we did. You can see for the THB 500,000 value, just only one month, we can sell 37 packages in one month. We just launched this one in July. You can see the online-offline part. Online is the THB 49 million, and offline is THB 13 million. Offline means we also have the physical gift card that sell in offline. People can come here to buy the physical gift card and give it to the patient in the IPD room, something like that. This concept is the new innovation concept that we are the first in Asia in hospital, that we have the gift card to send the new normal way to visit the patient. We can send via LINE as well currently, we also send via email, via chat, any chat that we can send right now. For application, BH Application, currently we have 58,000 people actively use our app right now. You can see we have incredible growth. In one day, we can grow more than the whole year, because we did the My Vaccination Record, that people can check about the vaccine, what is the first injection, the second injection, something like that. People have to link the HN with the date of birth security to see their own patient information. You can see we have the Android and iPhone. Bumrungrad, iPhone more than Android. It's 70%, and 30% is about Android. Okay, the next one. The next one, I update you about the feature that Application did. We have the new feature, six features, offer and voucher. Okay, I will show you how it is. Actually, it is integrated with the Online Store. When you purchase anything voucher from Online Store, it will automatically link the voucher to the Application. You just come here and open the Application. You can scan the barcode and treatment right away. After your treatment, you can go back home. No need to go cashier anymore because you already paid for the Online Store. We also have the birthday discount code 10%. This one we offer, we use the database of the Bumrungrad. Every month, we will have the people who birthday on that month, we offer 10% discount for them in Bumrungrad Online Store. They need to use Bumrungrad Application only to get this voucher to endorse them to use our Bumrungrad Application more. We can retargeting them as well. My Vaccination Record, the third one, is the new feature that we did and very success, and people load our app more and more, and use every day. They're going to keep this information for the whole life, because if you want to know your first injection of vaccine, second injection of vaccine, and another vaccine, you need to click on this menu. We can offer the additional vaccine in the future via this menu as well. The fourth one is about recommendation package. I will show you how it is. The fifth one is about the keyword suggestion for doctor search. Right now, we make the better search for doctor. You can search in specialty, last name, first name. You can search organ. You can search symptom, condition, treatment, all the things. The last one is about LINE official account. Currently, Thailand use the second in the world to use LINE. That's why we support LINE chat via our application as well. Okay, let's see detail. The first one is about offer and voucher. This one integrates with the BH Online Store part. When people buy anything from online store, the history of purchase will go inside the Bumrungrad Application. Application will have status to tell that it's active, it's used, it's expired, to remind the customer as well. We also have the birthday campaign in here, that on your birthday, birth month, you're going to get this voucher, and it's going to remind you to use it to discount the 10%. Okay, the second part, this one is about the voucher, the history of voucher, and the status of voucher. Any voucher that you purchase. You can use the barcode to scan in hospital and treatment right away. It also has the share icon. Right now, we make any purchase of the voucher, you can make it share to anyone you love. You can share to your family, your friend. You can share to anyone via any channel, because it's similar to the bank account. When you transfer bank account, it's going to save the picture of the transfer to the phone. You can forward that picture to anyone you love. But this barcode can use only one time in here. This is the new way to make every voucher as a gift. Okay, this one is the highlight one for the application this year. It's My Vaccination Record. You can see that all people concerned about the [Non-English content], right? Concerned about the date that to inject the vaccine, the first shot, the second shot, maybe the third shot, the fourth shot. We already make this thing happen for the Bumrungrad. You can see it's not show only the COVID vaccine. It show every vaccine that you inject in Bumrungrad. It have the date and time to tell you. In the future, it can make like a passport for you that you already have which vaccine you already have. You can see it show all the vaccine that you have in Bumrungrad. It's automatically show in here. Okay, for this one, it's about the keyword suggestion for doctor search. You can search the doctor name, last name, specialty, subspecialty, symptom, disease, and keyword. It will suggestion and you can find the doctor easier. You can click on the doctor. Currently, you can make appointment. In the future, you can make telemed appointment as well. Okay, next one is online integration. For the ask question in the application, we have LINE, we have Facebook Messenger, WhatsApp, and we can make call, we can make appointment into the application. We also support LINE, and we're going to support all the chat that support for each country, because we design this application not only for Thai, but we design for the global. This is the new feature that going to happen on the 26th of August. We will have the BKI free insurance for COVID vaccine. We're going to have the Japanese language support. We will have the podcast section. We will have the dynamic appointment confirmation. We will have the telemedicine integration. The first one, BKI. This one, anyone who going to come to Bumrungrad and inject the COVID vaccine, you can come to our app and click on the BKI and fill the form. You're going to get the free protection for the vaccine. If you have some effect with the vaccine, BKI will support you. This one going to happen on 23rd of August. This one is the Japanese version. We support Japanese people because we got the vaccine from embassy, Japanese embassy, to come to inject to Bumrungrad. We want them to have the version of Japanese to help them and the vaccination record to help the Japanese people as well. Currently, we have English, Thai and Japanese. We will have the Chinese and Arabic soon. It means we're going to support almost all the target customer that we have in Bumrungrad currently. Okay. For podcast. If anyone have the AirPlay or the Google Play, Android Auto, you can link the application BH app with that. It means that when you drive the car, you can listen the podcast of the Bumrungrad in car. We have this section up for the 23rd of August as well. This one is the feature of telemedicine integration. We already have the telemedicine for follow-up currently. We will have the appointment reminder. We will have the telemedicine reminder in here. People can click on the application to talk with the doctor right away. This is the old version of our telemed. We will have the new telemed on demand. It's going to happen in next month. This one is about e-Payment system. This is the new enhancement of e-Payment. We launched on the 16 June. Currently, people don't want to come to hospital because they worry about the COVID-19. We have the way to send the e-Payment link to them anywhere in the world, and they can click the link to make payment for family or for yourself or for anyone. We have the many option. Currently, we did our own payment system, and we can open and we can turn on, turn off for the any payment gateway in here. We not do only one payment gateway. We're going to do for multiple payment gateway in here. You can see we will have PayPal, we have Amex coming soon. We also did the WeLa payment gateway from ASEAN for the growth tourism for the whole Singaporean, all the thing. We already integrate in our e-Payment system as well. This one already support for future. Okay, this one is about the way you chat to the contact center. We also add the chat to the expert, chat with nurse, and to the clinic specifically. We can have the landing page specifically for heart, for any specific clinic. People can click to consult with the expert and chat directly to the nurse with our new system. We build the AI on top to become like a chatbot to try to find the FAQ, frequency ask question first. If that one cannot answer, it will forward to the right people to chat. It also link to the CRM case management part that we have SLA to answer the customer. This feature also available for any chat of the Bumrungrad and also on the BH application. Okay. We already roll out with the COVID center team, information team. If anyone have the question about the vaccine, about the COVID, they can come to our chat and ask. We have the mascot to be the chatbot currently. Okay, this is the look and feel how chatbot do. This is just version one. Actually, we already prepare our chatbot already support Thai, English, and Chinese. We're going to make it support for Japanese and Arabic later. Okay. That's all from me. Thank you. Thank you, Wisut. That concludes our second quarter 2021 analyst presentation. Stay tuned for the live Q&A session for those who are invited on the 19th of August. We will be posting this presentation to you on the 17th of August, so you'll have plenty of time to review and ask us any questions you may have. As usual, you can always contact us through all the regular channels. Thank you